DRUG OVERDOSE PREVENTION NEWSCAST

Having trouble viewing this email? View it as a Web page.

New DOP header

December 14, 2021

Here are your weekly updates from the Indiana Department of Health:

Effectiveness of Non-Opioid Interventions to Reduce Opioid Withdrawal Symptoms in Patients with Chronic Pain: A Systematic Review

Doctor writing a prescription

Opioid replacement therapy is commonly used for chronic non-cancer pain; however, the success rate varies and it is common for patients to suffer from several withdrawal symptoms. Since data have shown an increase in opioid prescription patients developing a dependency to the medication, researchers looked to better understand interventions to reduce opioid withdrawal symptoms. Specifically, this systematic review aimed to evaluate the effectiveness of different pharmacological, physical, psychological, and other treatments for withdrawal symptoms that occur during a medically-supervised opioid withdrawal treatment for adult patients with long-term opioid treatment for non-cancer chronic pain.

A systemic review was conducted utilizing online databases in which researchers collected all studies with controlled trials in adults with long-term opioid prescriptions for non-cancer pain. After the initial inclusion of 91 research papers, the researchers excluded all but one. Some of the reasons for exclusion were the use of illicit drugs from participants, animal trial, lack of description of the withdrawal symptoms, or an ongoing trial. Researchers concluded that there is a need for well-conducted randomized controlled trials to better understand opioid withdrawal symptoms for patients prescribed opioids. This review should draw attention to the data gap, stopping doctors and others in the medical industry from effectively treating the problem.


Pandemic Fuels Indiana's Drug Epidemic; Overdoses Spike

Shutdowns related to the pandemic led to isolations and a lack of recovery tools during an already existing substance abuse epidemic. In 2019, the Centers for Disease Control and Prevention reported 1,704 overdoses and preliminary numbers for 2020 indicate over 2,200 overdoses in the state of Indiana. Emily Bailey is a 26-year-old mother of two from Columbus, Indiana in long term recovery. Emily said that by age 15, she had tried heroin, meth, prescription drugs and others. She emphasized how difficult it was for her to get treatment and how depression was the leading cause of her drug misuse. She shares her story to highlight how hard it was to get treatment without the additional barriers to treatment created by the pandemic.

There are several efforts across the state in effect to target barriers to treatment and better understand the drug abuse epidemic. Melissa Cyders is an IUPUI associate professor working along the state's campaign called The Grand Challenge, which studies opioid addiction and recovery. Cyders said that she found individuals struggling with mental health and drug misuse affected the pandemic most. While many projects are in place for Hoosiers suffering from drug misuse, it is vital that we continue learning about these and sharing the information and resources.


Indiana Drug Overdose Dashboard

Drug Overdose Dashboard

Please visit the Indiana Drug Overdose Dashboard, where you will find data from 2017 up to provisional data for 2021. In this dashboard, you will find data regarding opioid prescriptions, hospital discharges, and drug-related deaths.

Follow us! @INDTrauma

twitter

Check out our website:

world wide web logo
light blue divider

UPCOMING EVENTS

light blue divider

Part 1: Understanding and Addressing the Social Determinants of Health in Prevention

2:30 p.m. – 4 p.m. EST, Dec. 14

This webinar will discuss the social determinants of health and how they are linked to inequity and health disparities. It will explain which aspects have been found to be significantly linked to substance use and discuss how they could be addressed. Another objective is to review racial and ethnic inequities in substance use risk and prevention services. This two-part webinar series will overview the social determinants of health, their influence on the risk of substance use, and recommendations on addressing them through environmental strategies.

To register for this event, click here.

light blue divider

Co-Occurring Mental Illness and Substance Use Disorder Treatment in the Black Community

1 p.m. - 2 p.m. EST, Dec. 16

Mental illness and substance use disorders often occur together. Co-occurrence may be a significant factor in the increased suicide rate in African Americans and the wave of opiate overdoses. This webinar will address why there is co-occurrence, both from a psychosocial and biological perspective. The presenter will also discuss how to develop effective treatment strategies and how to address comorbidities.

To register for this event, click here.

light blue divider

Safety & Health Integration in the Enforcement of Laws on Drugs (SHIELD)

9 a.m. – Noon EST, Jan. 17

Police officers have been asked to take on new roles and responsibilities due to overdoses and other emerging challenges. Usually, they are exposed to safety risks due to inadequate tools or training. This SHIELD Training Initiative fills this gap, providing law enforcement with the tools they need to safeguard their physical and mental well-being, improve community relations, and accomplish their public safety mission more efficiently.

To register for this event, click here.